admin

Welcome to the DermaSensor Newsroom. Here, you'll find the latest articles from skin-evaluation experts, discover emerging technology entering the market, and learn how general practitioners are adopting faster, easier, smarter tools to improve clinical decision making for their patients. See what the future standard of skin evaluation looks like, from Melbourne to Miami.

[custom-facebook-feed feed=1]

DermaSensor Announces Publication of Positive Results from Clinical Validation Study of Skin Cancer Detection Device

MIAMI, FLORIDA, USA, July 7, 2022 /EINPresswire.com/ — DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians (PCPs) to detect skin cancer, today announces the PATIENT-SELECT study results at the American Dermoscopy …

DermaSensor Announces Publication of Positive Results from Clinical Validation Study of Skin Cancer Detection Device Read More »

Company Successfully Completes First Ever FDA Pivotal Study for Skin Cancer Detection Device for Primary Care

MIAMI, FLORIDA, UNITED STATES, June 15, 2022 /EINPresswire.com/ Miami-Based DermaSensor, Inc. Raises Additional $10 Million To Prepare for U.S. Launch DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians (PCPs) …

Company Successfully Completes First Ever FDA Pivotal Study for Skin Cancer Detection Device for Primary Care Read More »

DermaSensor, Inc Announces Positive Results From Melanoma Clinical Validation Study of Skin Cancer Detection Device

DermaSensor’s optical spectroscopy and artificial intelligence technology demonstrated a 96% melanoma detection rate and a Negative Predictive Value of 98%. MIAMI, FL, U.S.A., March 29, 2022 /EINPresswire.com/ — DermaSensor Inc., a health technology company designing …

DermaSensor, Inc Announces Positive Results From Melanoma Clinical Validation Study of Skin Cancer Detection Device Read More »

Scroll to Top